Publications
-
Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma.
Vaysberg M,
Lambert SL, Krams SM, Martinez OM.
Am J Transplant.
2009;
9
(10):
2292-302
-
Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients.
Stenard F,
Nguyen C, Cox K, Kambham N, Umetsu DT, Krams SM, Esquivel CO, Martinez OM.
Pediatr Transplant.
2009;
13
(1):
70-80
-
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
Wai LE,
Fujiki M, Takeda S, Martinez OM, Krams SM.
Transplantation.
2008;
85
(1):
145-9
-
Epstein-Barr virus, rapamycin, and host immune responses.
Krams SM,
Martinez OM.
Curr Opin Organ Transplant.
2008;
13
(6):
563-8
-
Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.
Vaysberg M,
Hatton O, Lambert SL, Snow AL, Wong B, Krams SM, Martinez OM.
J Biol Chem.
2008;
283
(52):
36573-85
-
Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients.
Martinez OM,
de Gruijl FR.
Am J Transplant.
2008;
8
(11):
2205-11
-
Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10.
Lambert SL,
Martinez OM.
J Immunol.
2007;
179
(12):
8225-34
-
Epstein-Barr virus: evasive maneuvers in the development of PTLD.
Snow AL,
Martinez OM.
Am J Transplant.
2007;
7
(2):
271-7
-
Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression.
Vaysberg M,
Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM.
Transplantation.
2007;
83
(8):
1114-21
-
Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury.
Riddle-Taylor E,
Nagasaki K, Lopez J, Esquivel CO, Martinez OM, Krams SM.
Transplantation.
2007;
84
(6):
778-85
-
EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis.
Snow AL,
Vaysberg M, Krams SM, Martinez OM.
Am J Transplant.
2006;
6
(5 Pt 1):
976-85
-
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.
Snow AL,
Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM.
J Immunol.
2006;
177
(5):
3283-93
-
NKp30 is a functional activation receptor on a subset of rat natural killer cells.
Hsieh CL,
Nagasaki K, Martinez OM, Krams SM.
Eur J Immunol.
2006;
36
(8):
2170-80
-
CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes.
Li DH,
Tung JW, Tarner IH, Snow AL, Yukinari T, Ngernmaneepothong R, Martinez OM, Parnes JR.
J Immunol.
2006;
176
(9):
5321-8
-
IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses.
Obara H,
Nagasaki K, Hsieh CL, Ogura Y, Esquivel CO, Martinez OM, Krams SM.
Am J Transplant.
2005;
5
(9):
2094-103
-
Basic concepts in transplant immunology.
Martinez OM,
Rosen HR.
Liver Transpl.
2005;
11
(4):
370-81
-
Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts.
Hsieh CL,
Ogura Y, Obara H, Ali UA, Rodriguez GM, Nepomuceno RR, Martinez OM, Krams SM.
Transplantation.
2004;
77
(1):
121-8
-
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.
Nepomuceno RR,
Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM.
Cancer Res.
2003;
63
(15):
4472-80
-
Rapamycin Inhibits the Interleukin 10 Signal Transduction Pathway and the Growth of Epstein Barr Virus B-cell Lymphomas
Nepomuceno RR,
Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM.
Cancer Research.
2003;
63
(15):
4472
-
Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts.
Millan MT,
Natkunam Y, Clarke-Katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM.
Transplantation.
2002;
73
(3):
465-9
-
NK cells and transplantation.
Hsieh CL,
Obara H, Ogura Y, Martinez OM, Krams SM.
Transpl Immunol.
2002;
9
(2-4):
111-4
-
CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses.
Chan KW,
Hopke CD, Krams SM, Martinez OM.
J Immunol.
2002;
169
(4):
1784-91
-
Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorder.
Nepomuceno RR,
Snow AL, Robert Beatty P, Krams SM, Martinez OM.
Transplantation.
2002;
74
(3):
396-402
-
Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.
Falco DA,
Nepomuceno RR, Krams SM, Lee PP, Davis MM, Salvatierra O, Alexander SR, Esquivel CO, Cox KL, Frankel LR, Martinez OM.
Transplantation.
2002;
74
(4):
501-10
-
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis.
Fox CK,
Furtwaengler A, Nepomuceno RR, Martinez OM, Krams SM.
Liver.
2001;
21
(4):
272-9
-
Apoptosis and allograft rejection in the absence of CD8+ T cells.
Ogura Y,
Martinez OM, Villanueva JC, Tait JF, Strauss HW, Higgins JP, Tanaka K, Esquivel CO, Blankenberg FG, Krams SM.
Transplantation.
2001;
71
(12):
1827-34
-
Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway.
Snow AL,
Chen LJ, Nepomuceno RR, Krams SM, Esquivel CO, Martinez OM.
J Immunol.
2001;
167
(9):
5404-11
-
Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation.
Ogura Y,
Krams SM, Martinez OM, Kopiwoda S, Higgins JP, Esquivel CO, Strauss HW, Tait JF, Blankenberg FG.
Radiology.
2000;
214
(3):
795-800
-
Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
Krieger NR,
Martinez OM, Krams SM, Cox K, So S, Esquivel CO.
Liver Transpl.
2000;
6
(1):
62-6
-
Involvement of Fas-Fas ligand interactions in graft rejection.
Martinez OM,
Krams SM.
Int Rev Immunol.
1999;
18
(5-6):
527-46
-
Characterization of allograft rejection in an experimental model of small intestinal transplantation.
Hayashi M,
Martinez OM, Krams SM, Burns W, Esquivel CO.
J Gastrointest Surg.
1998 Jul-Aug;
2
(4):
325-32
-
Allograft rejection after liver transplantation for autoimmune liver diseases.
Hayashi M,
Keeffe EB, Krams SM, Martinez OM, Ojogho ON, So SK, Garcia G, Imperial JC, Esquivel CO.
Liver Transpl Surg.
1998;
4
(3):
208-14
-
Apoptosis as a mechanism of tissue injury in liver allograft rejection.
Krams SM,
Martinez OM.
Semin Liver Dis.
1998;
18
(2):
153-67
-
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
Beatty PR,
Krams SM, Esquivel CO, Martinez OM.
Transplantation.
1998;
65
(9):
1248-55
-
Human hepatocytes produce an isoform of FAS that inhibits apoptosis.
Krams SM,
Fox CK, Beatty PR, Cao S, Villanueva JC, Esquivel CO, Martinez OM.
Transplantation.
1998;
65
(5):
713-21
-
CD8+ cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation.
Krams SM,
Hayashi M, Fox CK, Villanueva JC, Whitmer KJ, Burns W, Esquivel CO, Martinez OM.
J Immunol.
1998;
160
(8):
3673-80
-
CD30 expression identifies a functional alloreactive human T-lymphocyte subset.
Martinez OM,
Villanueva J, Abtahi S, Beatty PR, Esquivel CO, Krams SM.
Transplantation.
1998;
65
(9):
1240-7
-
Cytokines are involved in the rejection of small intestine allografts.
Hayashi M,
Martinez OM, Krams SM, Burns W, Esquivel CO.
Transplant Proc.
1997;
29
(3):
1802
-
Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
Beatty PR,
Krams SM, Martinez OM.
J Immunol.
1997;
158
(9):
4045-51
-
Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30.
Krams SM,
Cao S, Hayashi M, Villanueva JC, Martinez OM.
Clin Immunol Immunopathol.
1996;
80
(3 Pt 1):
311-20
Help